Mr. Andreas Schieber – as a supervisory board representative of Medico Invest AG – has been appointed to set up the new organisation and will coordinate the group executive board. The structure of the new group executive board is as follows:
In addition, Mr. Markus Dorsch as chief quality officer (CQO) and Mr. Siegfried Eichinger as chief controlling officer (CCO) will complement the group executive board in a staff function. The market environment, regulatory requirements and product needs have significantly changed over the past few years, prompting Haselmeier to expedite its change process. The group executive board serves as the foundation for this change process. It will open a window allowing Haselmeier to gain a stronger foothold in the market, with new product innovations, a more efficient management of customer and development projects as well as a modern, sustainably safe and superior production.